Search

everythinglearnresearchcommunity

for

Search:↓

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

Hair loss linked to higher heart disease risk in both men and women.

Best hair growth results from combining finasteride and minoxidil.

TGF-β1 from dermal papilla cells suppresses hair growth, and targeting it may help treat androgenetic alopecia.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Neurosteroids show promise for treating epilepsy and more research is needed.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

Antimicrobial lotion reduces inflammation and increases hair density in hair loss patients.

Genetics play a role in acne, but how exactly they contribute is not fully understood.

SCF and c-Kit decrease in AGA hair follicles, possibly affecting hair pigmentation and growth.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Finasteride and flutamide both reduce hair growth, but finasteride has fewer side effects.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Finasteride reduces hirsutism effectively with fewer side effects but is a second-choice treatment due to safety concerns.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.